Literature DB >> 20537317

Ambulatory emotional reactivity to negative daily life events predicts remission from major depressive disorder.

Frenk Peeters1, Johannes Berkhof, Jonathan Rottenberg, Nancy A Nicolson.   

Abstract

Major depressive disorder (MDD) is often associated with altered emotional reactivity. However, the functional significance of altered emotional reactivity in MDD is uncertain. This study was the first to examine the predictive relationship between intensely sampled ambulatory emotional reactivity and the clinical course of MDD. Forty-six outpatients who met criteria for MDD underwent six days of experience sampling of their ambulatory reactivity to everyday negative and positive life events. After experience sampling, all outpatients received pharmacotherapy with supportive psychotherapy and were followed clinically for 18 months. At one month, less emotional reactivity to negative and positive daily events predicted higher depressive symptom severity. Importantly, patients who exhibited less negative emotional reactivity to daily negative life events were less likely to recover from MDD over the 18 month follow-up. Relationships between ambulatory emotional reactivity and MDD course were not accounted for by the duration or the severity of initial MDD symptoms. Diminished ambulatory emotional reactivity appears to be functionally significant in depression. Intensive sampling of ambulatory emotions may have utility for predicting the clinical course of MDD. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20537317     DOI: 10.1016/j.brat.2010.04.008

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  15 in total

1.  Negative Affect Instability among Individuals with Comorbid Borderline Personality Disorder and Posttraumatic Stress Disorder.

Authors:  Emily M Scheiderer; Ting Wang; Rachel L Tomko; Phillip K Wood; Timothy J Trull
Journal:  Clin Psychol Sci       Date:  2015-04-21

2.  Experience sampling methodology in mental health research: new insights and technical developments.

Authors:  Inez Myin-Germeys; Zuzana Kasanova; Thomas Vaessen; Hugo Vachon; Olivia Kirtley; Wolfgang Viechtbauer; Ulrich Reininghaus
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

3.  Depression symptoms moderate the association between emotion and communal behavior.

Authors:  Lance M Rappaport; D S Moskowitz; Bianca D'Antono
Journal:  J Couns Psychol       Date:  2017-02-20

4.  The Effects of Psychotherapy for Major Depressive Disorder on Daily Mood and Functioning: A Longitudinal Experience Sampling Study.

Authors:  Kari M Eddington; Chris J Burgin; Paul J Silvia; Niloofar Fallah; Catherine Majestic; Thomas R Kwapil
Journal:  Cognit Ther Res       Date:  2016-10-21

5.  Measuring affect dynamics: An empirical framework.

Authors:  Sergio Pirla; Maxime Taquet; Jordi Quoidbach
Journal:  Behav Res Methods       Date:  2022-04-05

6.  The wear and tear of daily stressors on mental health.

Authors:  Susan T Charles; Jennifer R Piazza; Jacqueline Mogle; Martin J Sliwinski; David M Almeida
Journal:  Psychol Sci       Date:  2013-03-26

Review 7.  Ambulatory assessment.

Authors:  Timothy J Trull; Ulrich Ebner-Priemer
Journal:  Annu Rev Clin Psychol       Date:  2012-11-13       Impact factor: 18.561

8.  Emotional responding in depression: distinctions in the time course of emotion.

Authors:  Erin K Moran; Neera Mehta; Ann M Kring
Journal:  Cogn Emot       Date:  2012-03-09

9.  Affect, Affective Variability, and Physical Health: Results from a Population-Based Investigation in China.

Authors:  Derwin K C Chan; Xin Zhang; Helene H Fung; Martin S Hagger
Journal:  Int J Behav Med       Date:  2016-08

10.  Personalized prescriptions of therapeutic skills from patient characteristics: An ecological momentary assessment approach.

Authors:  Christian A Webb; Marie Forgeard; Elana S Israel; Nathaniel Lovell-Smith; Courtney Beard; Thröstur Björgvinsson
Journal:  J Consult Clin Psychol       Date:  2021-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.